Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection
Abstract Hepatitis B virus (HBV) infection is one of the most common causes of viral hepatitis worldwide. Patients with persistent HBV infection may suffer from liver cirrhosis, hepatocellular carcinoma or hepatic failure. In this review, we mainly discuss the immunotherapy for HBV infection. At pre...
Saved in:
Main Authors: | Xuejie Wu (Author), Feng Xu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-mediated immunotherapy against chronic hepatitis B virus infection
by: Ying Gao, et al.
Published: (2017) -
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
by: Jinhong Chang, et al.
Published: (2014) -
Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
by: Shumin Luo, et al.
Published: (2023) -
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016) -
The burden of chronic hepatitis B virus infection in Australia, 2011
by: Jennifer H. MacLachlan, et al.
Published: (2013)